Source Photonics and Credo Semiconductor Demonstrate Single Lambda 100G Connectivity Over 20km of Fiber With Compact TOSA and ROSA Assemblies
ECOC -- Source Photonics and Credo Semiconductor are pleased to announce a single lambda 100Gbits/sec connectivity demonstration over 20km of fiber using a compact TOSA and ROSA capable of 53Gbaud PAM4 operation.
Increasing demand for more bandwidth in Cloud Data Centers is creating the need for more efficient and higher throughput optical transceivers beyond the currently deployed 100G 4x25G WDM technology. These next generation transceivers will need to support higher order modulation techniques such as PAM4 and higher data rate operation at 53Gbaud. Implementations that can be supported with this technology include 400G-DR4/FR4 in addition to 100G-DR/FR/LR.
The demonstration consists of Source Photonics internally packaged TOSA and ROSA sub-assemblies in an optical loopback configuration through 20km of single-mode fiber using a single 100G channel of Credo’s low power PAM4 IC technology. The bit-error-rate (BER) after 20km of fiber remained better than the KP4 FEC requirement and was around 5x10-5. The TOSA is based on Source Photonics’ EML laser technology which provides the necessary bandwidth to achieve a TDECQ value below 2.5dB. The room temperature link budget of 10dB provides considerable margin for the most significant link specifications under development in the industry, allowing production margin for performance variations. These results show that the building blocks necessary to realize 53Gbaud single lambda operation are available and ready to serve the needs of next generation data center deployments.
What this demonstration achieves with one laser and one receiver currently requires four lasers and four receivers – facilitating not only lower cost future 100G but also accelerating the development of 400G products.
“We are continuing to invest in next generation technology, such as Single Lambda 100G, as part of our commitment to providing leading edge solutions for data centers,” said Manish Mehta, EVP, PLM Source Photonics.
“The HyperScale Cloud Providers have spoken and 100G per lambda solutions are a key connectivity priority,” said Rajan Pai, Vice President of System Applications at Credo. “Our unique SerDes architecture allows us to deliver single-lane 100G performance at the lowest power which will enable the volume deployments of 100G and 400G optical modules.”
Source Photonics will be hosting a private demonstration at their booth number 162 at ECOC 2017 to be held in Gothenburg, Sweden from September 18-20, 2017. To schedule an appointment to view the demo, please contact Jasmin Basal at firstname.lastname@example.org.
About Source Photonics
Source Photonics is a leading provider of innovative and reliable optical communications technology that enables communications and connectivity in data centers, metro, and access networks. We invent next-generation solutions to provide customers with enabling technologies to support the rapidly increasing demands of cloud infrastructure, wireless communications, routing, and fiber-to-the-premises worldwide. Source Photonics is headquartered in West Hills, California, with manufacturing facilities, R&D, and sales offices worldwide. For more information about Source Photonics, please visit www.sourcephotonics.com.
About Credo Semiconductor
Credo is a leading provider of high performance, mixed-signal semiconductor solutions for the data center, enterprise networking and high performance computing markets. Credo's advanced Serializer-Deserializer (SerDes) technology delivers the bandwidth scalability and end-to-end signal integrity for next generation platforms requiring single-lane 25G, 50G, and 100G connectivity. The company makes its SerDes available in the form of Intellectual Property (IP) licensing on the most advanced processing nodes and with complementary product families focused on extending reach and multiplexing to higher data rates. Credo is headquartered in Milpitas, California and has offices in Shanghai and Hong Kong. For more information: www.credosemi.com
Jasmin Basal, 818-885-4202
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Enamine and TBD Biodiscovery Collaborate to Provide GMP-Based Services19.6.2018 11:08 | Tiedote
Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, and TBD Biodiscovery, a premium GMP manufacturer of fine chemicals including chemical active pharmaceutical ingredients (APIs), today announced they have entered into a collaboration agreement. The partnership aims to manage the transition of chemical synthesis of novel intermediates from laboratory to bulk scale under GMP standards utilizing Enamine’s know-how and process development expertise. This will help researchers meet the manufacturing feasibility criteria required for drug candidate selection, providing a rapid and cost effective scaled supply of new compounds. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180619005582/en/ Enamine’s catalogue of building blocks is the largest in the world and has been widely used by pharmaceutical companies for more than 15 years to develop lead compounds and drug candidat
IDEMIA Selected to Deliver Its Next Generation Fingerprint Matcher Engine as Part of the UK Home Office Biometrics Programme19.6.2018 10:54 | Tiedote
This award will result in the deployment of the very latest IDEMIA fingerprint matching platform, which will deliver significant productivity improvements by offering increased accuracy fingerprint services to the stakeholders and users of the HOB Programme. In the first phase of the project IDEMIA’s solution will be deployed for use by United Kingdom National Law Enforcement agencies, to be closely followed by Immigration and Border stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180619005576/en/ (Photo: IDEMIA) IDEMIA’s solution is based upon its MBSS Search Platform1 with additional Services. MBSS is a flagship product of IDEMIA, combining very high scalability (over 1 billion identities possible), very high availability – designed for mission-critical systems – and integrating IDEMIA’S world-leading biometric algorithms. The IDEMIA award results from a competitive procurement. Initially a five year contract,
Vincent Fournier Joins Binary Tree as Chief Innovation Officer19.6.2018 10:00 | Tiedote
Binary Tree has named Vincent Fournier as its first chief innovation officer, reporting to CEO Nick Wilkinson. In this critical executive management role, Vincent will lead a fast-paced, innovative, and collaborative team that helps power digital transformation. His team will develop new products and services to meet the urgent and pervasive needs of customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180619005126/en/ Vincent Fournier, Chief Innovation Officer at Binary Tree. (Photo: Business Wire) “The appointment of Vincent to this important new role is a key part of our strategy to define and accelerate the next phase of growth for Binary Tree and continue to drive our competitive advantage,” said Binary Tree CEO Nick Wilkinson. “We have a clear strategy, focused on transformation, innovation and the evolution of Binary Tree within the broader Microsoft ecosystem.” “I am thrilled to be joining Binary Tree during suc
Janssen Phase 3 Study Programme of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Presented for the First Time in Europe19.6.2018 09:00 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson presented for the first time in Europe data from pivotal Phase 3 clinical studies of the investigational compound esketamine nasal spray in treatment-resistant depression.1,2,3,4 The studies, conducted by Janssen Research & Development, LLC, were presented at the 31st International College of Neuropsychopharmacology (CINP) congress in Vienna, Austria. Data discussed from the Phase 3 programme included results from the maintenance phase of a long-term relapse prevention study in adults with treatment-resistant depression. The data found that continuing treatment with esketamine nasal spray plus an oral antidepressant in patients beyond 16 weeks showed clinically meaningful and statistically significant superiority to treatment with an oral antidepressant plus placebo nasal spray in delaying time to relapse of symptoms of depression. Furthermore, the data indicated that patients in stable remission treated with esketamine nasal sp
Rimini Street Announces $140 Million Refinancing19.6.2018 00:30 | Tiedote
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has entered into a binding agreement with a syndicate of investors, including a fourth round of equity participation by Rimini Street’s largest shareholder, Adams Street Partners, to refinance its current credit facility with the issuance of $140 million of Series A convertible preferred stock and 2.9 million shares of common stock. Closing is subject to a shareholder vote and certain other customary closing conditions. Holders of a majority of the Company’s common stock have agreed to vote in favor of the transaction, and the Company expects the transaction to close in the third quarter of 2018. The transaction is expected to unlock more than $95 million of cash flow over the next three years as compared to the current credit facility. The transaction extends the expected financing matu
Quanergy to Feature ‘Qortex for Security’ at IFSEC18.6.2018 23:30 | Tiedote
Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, today announced that it will be demonstrating its LiDAR-based security system at multiple booths during IFSEC International, Europe’s premier security trade show. This year’s conference will take place June 19-21, 2018 in London, UK. Quanergy’s security system, Qortex for Security, is an innovative, LiDAR-based 3D perimeter fencing and intrusion detection system. An integrated hardware and software platform, this intelligent security solution combines Quanergy’s M8 mechanical LiDAR sensor with its proprietary Qortex perception software. The platform is fully integrated into existing VMS (Video Management System) and PSIM (Physical Security Information Management) infrastructure and offers surveillance automation with real-time people detection, tracking and classification. “Qortex for Security is a prime example of the many benefits that LiDAR hardware and sof
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme